Global C1-INH Replacement Therapy Market Growth (Status and Outlook) 2026-2032
The global C1-INH Replacement Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
C1-INH replacement therapy is a treatment used to manage hereditary angioedema (HAE) by restoring the deficient or dysfunctional C1 esterase inhibitor (C1-INH) protein in patients.Replacement therapy involves administering C1-INH concentrates (e.g., Berinert, Cinryze, Haegarda), either during acute attacks or as a preventive measure, to normalize C1-INH levels, reducing the frequency and severity of HAE symptoms. It is available in intravenous or subcutaneous forms for flexible administration.
United States market for C1-INH Replacement Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for C1-INH Replacement Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for C1-INH Replacement Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key C1-INH Replacement Therapy players cover CSL Behring, Takeda, Pharming Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?C1-INH Replacement Therapy Industry Forecast? looks at past sales and reviews total world C1-INH Replacement Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected C1-INH Replacement Therapy sales for 2026 through 2032. With C1-INH Replacement Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world C1-INH Replacement Therapy industry.
This Insight Report provides a comprehensive analysis of the global C1-INH Replacement Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on C1-INH Replacement Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global C1-INH Replacement Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for C1-INH Replacement Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global C1-INH Replacement Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of C1-INH Replacement Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
C1-INH replacement therapy is a treatment used to manage hereditary angioedema (HAE) by restoring the deficient or dysfunctional C1 esterase inhibitor (C1-INH) protein in patients.Replacement therapy involves administering C1-INH concentrates (e.g., Berinert, Cinryze, Haegarda), either during acute attacks or as a preventive measure, to normalize C1-INH levels, reducing the frequency and severity of HAE symptoms. It is available in intravenous or subcutaneous forms for flexible administration.
United States market for C1-INH Replacement Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for C1-INH Replacement Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for C1-INH Replacement Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key C1-INH Replacement Therapy players cover CSL Behring, Takeda, Pharming Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?C1-INH Replacement Therapy Industry Forecast? looks at past sales and reviews total world C1-INH Replacement Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected C1-INH Replacement Therapy sales for 2026 through 2032. With C1-INH Replacement Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world C1-INH Replacement Therapy industry.
This Insight Report provides a comprehensive analysis of the global C1-INH Replacement Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on C1-INH Replacement Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global C1-INH Replacement Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for C1-INH Replacement Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global C1-INH Replacement Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of C1-INH Replacement Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Subcutaneous Injection
- Intravenous Injection
- Acquired Angioedema
- Hereditary Angioedema
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL Behring
- Takeda
- Pharming Healthcare
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global C1-INH Replacement Therapy Market Size (2021-2032)
2.1.2 C1-INH Replacement Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for C1-INH Replacement Therapy by Country/Region (2021, 2025 & 2032)
2.2 C1-INH Replacement Therapy Segment by Type
2.2.1 Subcutaneous Injection
2.2.2 Intravenous Injection
2.2.3 C1-INH Replacement Therapy Market Size by Type
2.2.3.1 C1-INH Replacement Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global C1-INH Replacement Therapy Market Size Market Share by Type (2021-2026)
2.3 C1-INH Replacement Therapy Segment by Application
2.3.1 Acquired Angioedema
2.3.2 Hereditary Angioedema
2.3.3 C1-INH Replacement Therapy Market Size by Application
2.3.3.1 C1-INH Replacement Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global C1-INH Replacement Therapy Market Size Market Share by Application (2021-2026)
3 C1-INH REPLACEMENT THERAPY MARKET SIZE BY PLAYER
3.1 C1-INH Replacement Therapy Market Size Market Share by Player
3.1.1 Global C1-INH Replacement Therapy Revenue by Player (2021-2026)
3.1.2 Global C1-INH Replacement Therapy Revenue Market Share by Player (2021-2026)
3.2 Global C1-INH Replacement Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 C1-INH REPLACEMENT THERAPY BY REGION
4.1 C1-INH Replacement Therapy Market Size by Region (2021-2026)
4.2 Global C1-INH Replacement Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas C1-INH Replacement Therapy Market Size Growth (2021-2026)
4.4 APAC C1-INH Replacement Therapy Market Size Growth (2021-2026)
4.5 Europe C1-INH Replacement Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa C1-INH Replacement Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas C1-INH Replacement Therapy Market Size by Country (2021-2026)
5.2 Americas C1-INH Replacement Therapy Market Size by Type (2021-2026)
5.3 Americas C1-INH Replacement Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC C1-INH Replacement Therapy Market Size by Region (2021-2026)
6.2 APAC C1-INH Replacement Therapy Market Size by Type (2021-2026)
6.3 APAC C1-INH Replacement Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe C1-INH Replacement Therapy Market Size by Country (2021-2026)
7.2 Europe C1-INH Replacement Therapy Market Size by Type (2021-2026)
7.3 Europe C1-INH Replacement Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa C1-INH Replacement Therapy by Region (2021-2026)
8.2 Middle East & Africa C1-INH Replacement Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa C1-INH Replacement Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL C1-INH REPLACEMENT THERAPY MARKET FORECAST
10.1 Global C1-INH Replacement Therapy Forecast by Region (2027-2032)
10.1.1 Global C1-INH Replacement Therapy Forecast by Region (2027-2032)
10.1.2 Americas C1-INH Replacement Therapy Forecast
10.1.3 APAC C1-INH Replacement Therapy Forecast
10.1.4 Europe C1-INH Replacement Therapy Forecast
10.1.5 Middle East & Africa C1-INH Replacement Therapy Forecast
10.2 Americas C1-INH Replacement Therapy Forecast by Country (2027-2032)
10.2.1 United States Market C1-INH Replacement Therapy Forecast
10.2.2 Canada Market C1-INH Replacement Therapy Forecast
10.2.3 Mexico Market C1-INH Replacement Therapy Forecast
10.2.4 Brazil Market C1-INH Replacement Therapy Forecast
10.3 APAC C1-INH Replacement Therapy Forecast by Region (2027-2032)
10.3.1 China C1-INH Replacement Therapy Market Forecast
10.3.2 Japan Market C1-INH Replacement Therapy Forecast
10.3.3 Korea Market C1-INH Replacement Therapy Forecast
10.3.4 Southeast Asia Market C1-INH Replacement Therapy Forecast
10.3.5 India Market C1-INH Replacement Therapy Forecast
10.3.6 Australia Market C1-INH Replacement Therapy Forecast
10.4 Europe C1-INH Replacement Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market C1-INH Replacement Therapy Forecast
10.4.2 France Market C1-INH Replacement Therapy Forecast
10.4.3 UK Market C1-INH Replacement Therapy Forecast
10.4.4 Italy Market C1-INH Replacement Therapy Forecast
10.4.5 Russia Market C1-INH Replacement Therapy Forecast
10.5 Middle East & Africa C1-INH Replacement Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market C1-INH Replacement Therapy Forecast
10.5.2 South Africa Market C1-INH Replacement Therapy Forecast
10.5.3 Israel Market C1-INH Replacement Therapy Forecast
10.5.4 Turkey Market C1-INH Replacement Therapy Forecast
10.6 Global C1-INH Replacement Therapy Forecast by Type (2027-2032)
10.7 Global C1-INH Replacement Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market C1-INH Replacement Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 CSL Behring
11.1.1 CSL Behring Company Information
11.1.2 CSL Behring C1-INH Replacement Therapy Product Offered
11.1.3 CSL Behring C1-INH Replacement Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 CSL Behring Main Business Overview
11.1.5 CSL Behring Latest Developments
11.2 Takeda
11.2.1 Takeda Company Information
11.2.2 Takeda C1-INH Replacement Therapy Product Offered
11.2.3 Takeda C1-INH Replacement Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Takeda Main Business Overview
11.2.5 Takeda Latest Developments
11.3 Pharming Healthcare
11.3.1 Pharming Healthcare Company Information
11.3.2 Pharming Healthcare C1-INH Replacement Therapy Product Offered
11.3.3 Pharming Healthcare C1-INH Replacement Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Pharming Healthcare Main Business Overview
11.3.5 Pharming Healthcare Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global C1-INH Replacement Therapy Market Size (2021-2032)
2.1.2 C1-INH Replacement Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for C1-INH Replacement Therapy by Country/Region (2021, 2025 & 2032)
2.2 C1-INH Replacement Therapy Segment by Type
2.2.1 Subcutaneous Injection
2.2.2 Intravenous Injection
2.2.3 C1-INH Replacement Therapy Market Size by Type
2.2.3.1 C1-INH Replacement Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global C1-INH Replacement Therapy Market Size Market Share by Type (2021-2026)
2.3 C1-INH Replacement Therapy Segment by Application
2.3.1 Acquired Angioedema
2.3.2 Hereditary Angioedema
2.3.3 C1-INH Replacement Therapy Market Size by Application
2.3.3.1 C1-INH Replacement Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global C1-INH Replacement Therapy Market Size Market Share by Application (2021-2026)
3 C1-INH REPLACEMENT THERAPY MARKET SIZE BY PLAYER
3.1 C1-INH Replacement Therapy Market Size Market Share by Player
3.1.1 Global C1-INH Replacement Therapy Revenue by Player (2021-2026)
3.1.2 Global C1-INH Replacement Therapy Revenue Market Share by Player (2021-2026)
3.2 Global C1-INH Replacement Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 C1-INH REPLACEMENT THERAPY BY REGION
4.1 C1-INH Replacement Therapy Market Size by Region (2021-2026)
4.2 Global C1-INH Replacement Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas C1-INH Replacement Therapy Market Size Growth (2021-2026)
4.4 APAC C1-INH Replacement Therapy Market Size Growth (2021-2026)
4.5 Europe C1-INH Replacement Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa C1-INH Replacement Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas C1-INH Replacement Therapy Market Size by Country (2021-2026)
5.2 Americas C1-INH Replacement Therapy Market Size by Type (2021-2026)
5.3 Americas C1-INH Replacement Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC C1-INH Replacement Therapy Market Size by Region (2021-2026)
6.2 APAC C1-INH Replacement Therapy Market Size by Type (2021-2026)
6.3 APAC C1-INH Replacement Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe C1-INH Replacement Therapy Market Size by Country (2021-2026)
7.2 Europe C1-INH Replacement Therapy Market Size by Type (2021-2026)
7.3 Europe C1-INH Replacement Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa C1-INH Replacement Therapy by Region (2021-2026)
8.2 Middle East & Africa C1-INH Replacement Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa C1-INH Replacement Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL C1-INH REPLACEMENT THERAPY MARKET FORECAST
10.1 Global C1-INH Replacement Therapy Forecast by Region (2027-2032)
10.1.1 Global C1-INH Replacement Therapy Forecast by Region (2027-2032)
10.1.2 Americas C1-INH Replacement Therapy Forecast
10.1.3 APAC C1-INH Replacement Therapy Forecast
10.1.4 Europe C1-INH Replacement Therapy Forecast
10.1.5 Middle East & Africa C1-INH Replacement Therapy Forecast
10.2 Americas C1-INH Replacement Therapy Forecast by Country (2027-2032)
10.2.1 United States Market C1-INH Replacement Therapy Forecast
10.2.2 Canada Market C1-INH Replacement Therapy Forecast
10.2.3 Mexico Market C1-INH Replacement Therapy Forecast
10.2.4 Brazil Market C1-INH Replacement Therapy Forecast
10.3 APAC C1-INH Replacement Therapy Forecast by Region (2027-2032)
10.3.1 China C1-INH Replacement Therapy Market Forecast
10.3.2 Japan Market C1-INH Replacement Therapy Forecast
10.3.3 Korea Market C1-INH Replacement Therapy Forecast
10.3.4 Southeast Asia Market C1-INH Replacement Therapy Forecast
10.3.5 India Market C1-INH Replacement Therapy Forecast
10.3.6 Australia Market C1-INH Replacement Therapy Forecast
10.4 Europe C1-INH Replacement Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market C1-INH Replacement Therapy Forecast
10.4.2 France Market C1-INH Replacement Therapy Forecast
10.4.3 UK Market C1-INH Replacement Therapy Forecast
10.4.4 Italy Market C1-INH Replacement Therapy Forecast
10.4.5 Russia Market C1-INH Replacement Therapy Forecast
10.5 Middle East & Africa C1-INH Replacement Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market C1-INH Replacement Therapy Forecast
10.5.2 South Africa Market C1-INH Replacement Therapy Forecast
10.5.3 Israel Market C1-INH Replacement Therapy Forecast
10.5.4 Turkey Market C1-INH Replacement Therapy Forecast
10.6 Global C1-INH Replacement Therapy Forecast by Type (2027-2032)
10.7 Global C1-INH Replacement Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market C1-INH Replacement Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 CSL Behring
11.1.1 CSL Behring Company Information
11.1.2 CSL Behring C1-INH Replacement Therapy Product Offered
11.1.3 CSL Behring C1-INH Replacement Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 CSL Behring Main Business Overview
11.1.5 CSL Behring Latest Developments
11.2 Takeda
11.2.1 Takeda Company Information
11.2.2 Takeda C1-INH Replacement Therapy Product Offered
11.2.3 Takeda C1-INH Replacement Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Takeda Main Business Overview
11.2.5 Takeda Latest Developments
11.3 Pharming Healthcare
11.3.1 Pharming Healthcare Company Information
11.3.2 Pharming Healthcare C1-INH Replacement Therapy Product Offered
11.3.3 Pharming Healthcare C1-INH Replacement Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Pharming Healthcare Main Business Overview
11.3.5 Pharming Healthcare Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. C1-INH Replacement Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. C1-INH Replacement Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Subcutaneous Injection
Table 4. Major Players of Intravenous Injection
Table 5. C1-INH Replacement Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global C1-INH Replacement Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global C1-INH Replacement Therapy Market Size Market Share by Type (2021-2026)
Table 8. C1-INH Replacement Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global C1-INH Replacement Therapy Market Size by Application (2021-2026) & ($ millions)
Table 10. Global C1-INH Replacement Therapy Market Size Market Share by Application (2021-2026)
Table 11. Global C1-INH Replacement Therapy Revenue by Player (2021-2026) & ($ millions)
Table 12. Global C1-INH Replacement Therapy Revenue Market Share by Player (2021-2026)
Table 13. C1-INH Replacement Therapy Key Players Head office and Products Offered
Table 14. C1-INH Replacement Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global C1-INH Replacement Therapy Market Size by Region (2021-2026) & ($ millions)
Table 18. Global C1-INH Replacement Therapy Market Size Market Share by Region (2021-2026)
Table 19. Global C1-INH Replacement Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global C1-INH Replacement Therapy Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas C1-INH Replacement Therapy Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas C1-INH Replacement Therapy Market Size Market Share by Country (2021-2026)
Table 23. Americas C1-INH Replacement Therapy Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas C1-INH Replacement Therapy Market Size Market Share by Type (2021-2026)
Table 25. Americas C1-INH Replacement Therapy Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas C1-INH Replacement Therapy Market Size Market Share by Application (2021-2026)
Table 27. APAC C1-INH Replacement Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC C1-INH Replacement Therapy Market Size Market Share by Region (2021-2026)
Table 29. APAC C1-INH Replacement Therapy Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC C1-INH Replacement Therapy Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe C1-INH Replacement Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe C1-INH Replacement Therapy Market Size Market Share by Country (2021-2026)
Table 33. Europe C1-INH Replacement Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe C1-INH Replacement Therapy Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa C1-INH Replacement Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa C1-INH Replacement Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa C1-INH Replacement Therapy Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of C1-INH Replacement Therapy
Table 39. Key Market Challenges & Risks of C1-INH Replacement Therapy
Table 40. Key Industry Trends of C1-INH Replacement Therapy
Table 41. Global C1-INH Replacement Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global C1-INH Replacement Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global C1-INH Replacement Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global C1-INH Replacement Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. CSL Behring Details, Company Type, C1-INH Replacement Therapy Area Served and Its Competitors
Table 46. CSL Behring C1-INH Replacement Therapy Product Offered
Table 47. CSL Behring C1-INH Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. CSL Behring Main Business
Table 49. CSL Behring Latest Developments
Table 50. Takeda Details, Company Type, C1-INH Replacement Therapy Area Served and Its Competitors
Table 51. Takeda C1-INH Replacement Therapy Product Offered
Table 52. Takeda C1-INH Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Takeda Main Business
Table 54. Takeda Latest Developments
Table 55. Pharming Healthcare Details, Company Type, C1-INH Replacement Therapy Area Served and Its Competitors
Table 56. Pharming Healthcare C1-INH Replacement Therapy Product Offered
Table 57. Pharming Healthcare C1-INH Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Pharming Healthcare Main Business
Table 59. Pharming Healthcare Latest Developments
Table 1. C1-INH Replacement Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. C1-INH Replacement Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Subcutaneous Injection
Table 4. Major Players of Intravenous Injection
Table 5. C1-INH Replacement Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global C1-INH Replacement Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global C1-INH Replacement Therapy Market Size Market Share by Type (2021-2026)
Table 8. C1-INH Replacement Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global C1-INH Replacement Therapy Market Size by Application (2021-2026) & ($ millions)
Table 10. Global C1-INH Replacement Therapy Market Size Market Share by Application (2021-2026)
Table 11. Global C1-INH Replacement Therapy Revenue by Player (2021-2026) & ($ millions)
Table 12. Global C1-INH Replacement Therapy Revenue Market Share by Player (2021-2026)
Table 13. C1-INH Replacement Therapy Key Players Head office and Products Offered
Table 14. C1-INH Replacement Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global C1-INH Replacement Therapy Market Size by Region (2021-2026) & ($ millions)
Table 18. Global C1-INH Replacement Therapy Market Size Market Share by Region (2021-2026)
Table 19. Global C1-INH Replacement Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global C1-INH Replacement Therapy Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas C1-INH Replacement Therapy Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas C1-INH Replacement Therapy Market Size Market Share by Country (2021-2026)
Table 23. Americas C1-INH Replacement Therapy Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas C1-INH Replacement Therapy Market Size Market Share by Type (2021-2026)
Table 25. Americas C1-INH Replacement Therapy Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas C1-INH Replacement Therapy Market Size Market Share by Application (2021-2026)
Table 27. APAC C1-INH Replacement Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC C1-INH Replacement Therapy Market Size Market Share by Region (2021-2026)
Table 29. APAC C1-INH Replacement Therapy Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC C1-INH Replacement Therapy Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe C1-INH Replacement Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe C1-INH Replacement Therapy Market Size Market Share by Country (2021-2026)
Table 33. Europe C1-INH Replacement Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe C1-INH Replacement Therapy Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa C1-INH Replacement Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa C1-INH Replacement Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa C1-INH Replacement Therapy Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of C1-INH Replacement Therapy
Table 39. Key Market Challenges & Risks of C1-INH Replacement Therapy
Table 40. Key Industry Trends of C1-INH Replacement Therapy
Table 41. Global C1-INH Replacement Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global C1-INH Replacement Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global C1-INH Replacement Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global C1-INH Replacement Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. CSL Behring Details, Company Type, C1-INH Replacement Therapy Area Served and Its Competitors
Table 46. CSL Behring C1-INH Replacement Therapy Product Offered
Table 47. CSL Behring C1-INH Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. CSL Behring Main Business
Table 49. CSL Behring Latest Developments
Table 50. Takeda Details, Company Type, C1-INH Replacement Therapy Area Served and Its Competitors
Table 51. Takeda C1-INH Replacement Therapy Product Offered
Table 52. Takeda C1-INH Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Takeda Main Business
Table 54. Takeda Latest Developments
Table 55. Pharming Healthcare Details, Company Type, C1-INH Replacement Therapy Area Served and Its Competitors
Table 56. Pharming Healthcare C1-INH Replacement Therapy Product Offered
Table 57. Pharming Healthcare C1-INH Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Pharming Healthcare Main Business
Table 59. Pharming Healthcare Latest Developments
LIST OF FIGURES
Figure 1. C1-INH Replacement Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global C1-INH Replacement Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. C1-INH Replacement Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. C1-INH Replacement Therapy Sales Market Share by Country/Region (2025)
Figure 8. C1-INH Replacement Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global C1-INH Replacement Therapy Market Size Market Share by Type in 2025
Figure 10. C1-INH Replacement Therapy in Acquired Angioedema
Figure 11. Global C1-INH Replacement Therapy Market: Acquired Angioedema (2021-2026) & ($ millions)
Figure 12. C1-INH Replacement Therapy in Hereditary Angioedema
Figure 13. Global C1-INH Replacement Therapy Market: Hereditary Angioedema (2021-2026) & ($ millions)
Figure 14. Global C1-INH Replacement Therapy Market Size Market Share by Application in 2025
Figure 15. Global C1-INH Replacement Therapy Revenue Market Share by Player in 2025
Figure 16. Global C1-INH Replacement Therapy Market Size Market Share by Region (2021-2026)
Figure 17. Americas C1-INH Replacement Therapy Market Size 2021-2026 ($ millions)
Figure 18. APAC C1-INH Replacement Therapy Market Size 2021-2026 ($ millions)
Figure 19. Europe C1-INH Replacement Therapy Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa C1-INH Replacement Therapy Market Size 2021-2026 ($ millions)
Figure 21. Americas C1-INH Replacement Therapy Value Market Share by Country in 2025
Figure 22. United States C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC C1-INH Replacement Therapy Market Size Market Share by Region in 2025
Figure 27. APAC C1-INH Replacement Therapy Market Size Market Share by Type (2021-2026)
Figure 28. APAC C1-INH Replacement Therapy Market Size Market Share by Application (2021-2026)
Figure 29. China C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. India C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe C1-INH Replacement Therapy Market Size Market Share by Country in 2025
Figure 36. Europe C1-INH Replacement Therapy Market Size Market Share by Type (2021-2026)
Figure 37. Europe C1-INH Replacement Therapy Market Size Market Share by Application (2021-2026)
Figure 38. Germany C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. France C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. UK C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa C1-INH Replacement Therapy Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa C1-INH Replacement Therapy Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa C1-INH Replacement Therapy Market Size Market Share by Application (2021-2026)
Figure 46. Egypt C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 52. APAC C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 53. Europe C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 55. United States C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 56. Canada C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 57. Mexico C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 58. Brazil C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 59. China C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 60. Japan C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 61. Korea C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 63. India C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 64. Australia C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 65. Germany C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 66. France C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 67. UK C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 68. Italy C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 69. Russia C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 70. Egypt C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 71. South Africa C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 72. Israel C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 73. Turkey C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 74. Global C1-INH Replacement Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global C1-INH Replacement Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 1. C1-INH Replacement Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global C1-INH Replacement Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. C1-INH Replacement Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. C1-INH Replacement Therapy Sales Market Share by Country/Region (2025)
Figure 8. C1-INH Replacement Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global C1-INH Replacement Therapy Market Size Market Share by Type in 2025
Figure 10. C1-INH Replacement Therapy in Acquired Angioedema
Figure 11. Global C1-INH Replacement Therapy Market: Acquired Angioedema (2021-2026) & ($ millions)
Figure 12. C1-INH Replacement Therapy in Hereditary Angioedema
Figure 13. Global C1-INH Replacement Therapy Market: Hereditary Angioedema (2021-2026) & ($ millions)
Figure 14. Global C1-INH Replacement Therapy Market Size Market Share by Application in 2025
Figure 15. Global C1-INH Replacement Therapy Revenue Market Share by Player in 2025
Figure 16. Global C1-INH Replacement Therapy Market Size Market Share by Region (2021-2026)
Figure 17. Americas C1-INH Replacement Therapy Market Size 2021-2026 ($ millions)
Figure 18. APAC C1-INH Replacement Therapy Market Size 2021-2026 ($ millions)
Figure 19. Europe C1-INH Replacement Therapy Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa C1-INH Replacement Therapy Market Size 2021-2026 ($ millions)
Figure 21. Americas C1-INH Replacement Therapy Value Market Share by Country in 2025
Figure 22. United States C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC C1-INH Replacement Therapy Market Size Market Share by Region in 2025
Figure 27. APAC C1-INH Replacement Therapy Market Size Market Share by Type (2021-2026)
Figure 28. APAC C1-INH Replacement Therapy Market Size Market Share by Application (2021-2026)
Figure 29. China C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. India C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe C1-INH Replacement Therapy Market Size Market Share by Country in 2025
Figure 36. Europe C1-INH Replacement Therapy Market Size Market Share by Type (2021-2026)
Figure 37. Europe C1-INH Replacement Therapy Market Size Market Share by Application (2021-2026)
Figure 38. Germany C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. France C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. UK C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa C1-INH Replacement Therapy Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa C1-INH Replacement Therapy Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa C1-INH Replacement Therapy Market Size Market Share by Application (2021-2026)
Figure 46. Egypt C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries C1-INH Replacement Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 52. APAC C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 53. Europe C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 55. United States C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 56. Canada C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 57. Mexico C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 58. Brazil C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 59. China C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 60. Japan C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 61. Korea C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 63. India C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 64. Australia C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 65. Germany C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 66. France C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 67. UK C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 68. Italy C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 69. Russia C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 70. Egypt C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 71. South Africa C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 72. Israel C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 73. Turkey C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
Figure 74. Global C1-INH Replacement Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global C1-INH Replacement Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries C1-INH Replacement Therapy Market Size 2027-2032 ($ millions)
